Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target

Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target

Bibliographic Details
Main Authors:	Karan Govindpani, Chitra Vinnakota, Henry J Waldvogel, Richard L Faull, Andrea Kwakowsky
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Neural Regeneration Research
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=6;spage=1030;epage=1032;aulast=Govindpani

Similar Items

Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?
by: Karan Govindpani, et al.
Published: (2019-05-01)

Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease
by: Karan Govindpani, et al.
Published: (2017-08-01)

Impaired Expression of GABA Signaling Components in the Alzheimer’s Disease Middle Temporal Gyrus
by: Karan Govindpani, et al.
Published: (2020-11-01)

Gamma-aminobutyric acid A receptors in Alzheimer's disease: highly localized remodeling of a complex and diverse signaling pathway
by: Andrea Kwakowsky, et al.
Published: (2018-01-01)

Therapeutic potential of alpha 5 subunit containing GABAA receptors in Alzheimer’s disease
by: Andrea Kwakowsky, et al.
Published: (2021-01-01)

Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer’s Disease
by: Andrea Kwakowsky, et al.
Published: (2016-12-01)

An 5 GABAA Receptor Inverse Agonist, 5IA, Attenuates Amyloid Beta-Induced Neuronal Death in Mouse Hippocampal Cultures
by: Chitra Vinnakota, et al.
Published: (2020-05-01)

The Role of Microglia and Astrocytes in Huntington’s Disease
by: Thulani H. Palpagama, et al.
Published: (2019-10-01)

EAAT2 Expression in the Hippocampus, Subiculum, Entorhinal Cortex and Superior Temporal Gyrus in Alzheimer’s Disease
by: Jason H. Y. Yeung, et al.
Published: (2021-09-01)

Retinal Dysfunction in Alzheimer’s Disease and Implications for Biomarkers
by: Chunyan Liao, et al.
Published: (2021-08-01)

Dysfunction of axonal transport in normal-tension glaucoma: a biomarker of disease progression and a potential therapeutic target
by: Kazuyuki Hirooka, et al.
Published: (2021-01-01)

The effects of amyloid-beta on hippocampal glutamatergic receptor and transporter expression
by: Andrea Kwakowsky, et al.
Published: (2021-01-01)

Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer’s Disease
by: Yin Q, et al.
Published: (2020-02-01)

The biomarkers and targeting treatment for Alzheimer's disease
by: Zheng WANG, et al.
Published: (2010-04-01)

Mitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future?
by: Simon M. Bell, et al.
Published: (2021-01-01)

ENDOTHELIAL GLYCOCALYX — POTENTIAL VASCULAR BIOMARKER: DIAGNOSTIC AND THERAPEUTIC TARGET IN CARDIOVASCULAR DISEASES
by: A. Yu. Gorshkov, et al.
Published: (2015-12-01)

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
by: Marwan N. Sabbagh, et al.
Published: (2019-12-01)

Molecular biomarkers of Alzheimer's disease: progress and prospects
by: Tammaryn Lashley, et al.
Published: (2018-05-01)

New Therapeutic Targets in Alzheimer's Disease
by: Horia Coman, et al.
Published: (2017-03-01)

A systematic review of biomarkers for disease progression in Alzheimer's disease.
by: David J M McGhee, et al.
Published: (2014-01-01)

Role of Neuron and Glia in Alzheimer’s Disease and Associated Vascular Dysfunction
by: Sanghamitra Bandyopadhyay, et al.
Published: (2021-06-01)

Fluid biomarkers in clinical trials of Alzheimer’s disease therapeutics
by: Aaron eRitter, et al.
Published: (2015-08-01)

The nuclear receptor PPARγ as a therapeutic target for cerebrovascular and brain dysfunction in Alzheimer's disease
by: Nektaria Nicolakakis, et al.
Published: (2010-05-01)

Impact of vascular diseases on the progression of mild cognitive impairment to Alzheimer’s disease
by: Marta Nesteruk, et al.
Published: (2015-04-01)

Learning Biomarker Models for Progression Estimation of Alzheimer's Disease.
by: Alexander Schmidt-Richberg, et al.
Published: (2016-01-01)

Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer’s Disease
by: Annika Öhrfelt, et al.
Published: (2011-01-01)

Metabolic and Vascular Imaging Biomarkers for Brain Aging and Alzheimer's Disease
Published: (2020)

Correction: A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease
by: The Staff
Published: (2014-01-01)

Correction: A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease.
Published: (2014-01-01)

Discovering Biomarkers and Pathways Shared by Alzheimer’s Disease and Ischemic Stroke to Identify Novel Therapeutic Targets
by: Md. Rezanur Rahman, et al.
Published: (2019-05-01)

NUCLEAR RECEPTORS AS THERAPEUTIC TARGETS FOR ALZHEIMER’S DISEASE
by: Courtney, Rebecca
Published: (2017)

Rho GTPases as therapeutic targets in Alzheimer’s disease
by: Byron J. Aguilar, et al.
Published: (2017-12-01)

Progress on the visual dysfunction after Alzheimer's disease and its mechanism
by: Qing Sang, et al.
Published: (2018-06-01)

Progress in the study on neuroimaging of Alzheimer's disease and vascular cognitive impairment
by: Fei MIAO, et al.
Published: (2010-06-01)

Vascular α1A Adrenergic Receptors as a Potential Therapeutic Target for IPAD in Alzheimer’s Disease
by: Miles Frost, et al.
Published: (2020-09-01)

Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
by: Yuek Ling Chai, et al.
Published: (2021-02-01)

Estimation of biomarker candidates for Alzheimer’s disease and/or vascular dementia in Taiwanese population
by: Hsiu-Kuan Wang, et al.

Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
by: Nicholas C. Cullen, et al.
Published: (2020-09-01)

The Role of Non-coding RNAs in Alzheimer’s Disease: From Regulated Mechanism to Therapeutic Targets and Diagnostic Biomarkers
by: Yuan Zhang, et al.
Published: (2021-07-01)

Potential Therapeutic Role of Phytochemicals to Mitigate Mitochondrial Dysfunctions in Alzheimer’s Disease
by: Md. Ataur Rahman, et al.
Published: (2021-12-01)